The nine RYR1 mutations identified in both animal models and human NASH-HCCs were located across the whole gene, with 3 stop gains or truncating mutations inferring likely loss-of-function mutations [100]. This evidence concerns the gene RYR1 and metabolic dysfunction-associated steatohepatitis.